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Summary
Objective: The present study was conducted on transgenic Del1 (+/−) mice harboring six copies of a transgene with small deletion mutation
engineered into mouse type II collagen gene. Incorporation of transgene into mouse genome was predicted to cause reduced mechanical
strength of articular cartilage with deposition of structurally inferior collagen network and consequently to predispose the animal to
early-onset joint degeneration.
Design: Progression of degenerative chances in the knee joints of Del1 (+/−) and control mice was followed by macroscopic and histologic
analyses at 3–5 month intervals between 3 and 22 months of age. Expression and distribution of type II collagen was studied with Northern
hybridization, RNase protection assay and immunohistochemistry.
Results: Articular cartilage degeneration began with superficial fibrillation at the age of 3 months in Del1 (+/−) mice. These changes
coincided with a significant reduction in the expression of both endogenous and transgene-derived type II collagen mRNA. The defects
gradually progressed into erosions penetrating the articular cartilage, bony sclerosis, degeneration of menisci, mineralization of various joint
structures, cyst formation and exposure of subchondral bone. Nontransgenic controls also developed osteoarthritic lesions, but these
appeared significantly later and were less severe. Increased transcription of type IIA procollagen mRNA, typical for chondroprogenitor cells
and cartilage repair was also observed at six months in Del1 (+/−) mice.
Conclusion: These findings suggest that the impact of truncated type II collagen transgene, together with maturation-related reduction in type
II collagen production significantly contribute to the early-onset degeneration of knee joints in Del1 (+/−) mice. These mice with
osteoarthritis-like phenotype should provide a useful model for studies on the early pathogenic mechanisms involved in articular cartilage
degeneration. © 2000 OsteoArthritis Research Society International
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The etiopathogenesis of osteoarthritis (OA) is a multifacto-
rial process and includes both genetic and environmental
factors.1,2 The disease is traditionally divided into primary
(idiopathic) and secondary forms. The latter is distin-
guished from the former by the presence of predisposing
conditions, such as injury, congenital abnormality, occupa-
tional stress, obesity or alterations in joint biomechanics.
The genetic component in OA is also heterogeneous.
Mutations known to confer susceptibility to familial OA
involve structural components of cartilaginous extracellular
matrix, which is composed of interacting collagens and248proteoglycans. These two classes of molecules provide
cartilage with its unique shock absorptive properties: the
collagen network is responsible for the structural strength
and the entrapped proteoglycans for the resilience of the
tissue. Cartilage collagens form heterotypic fibrils consist-
ing of type II, IX and XI collagens.3,4 The major component
of the fibrils is type II collagen, a homotrimer of three
identical 1(II)-chains. Type II collagen is expressed in two
alternatively spliced forms.5 The longer splice variant, type
IIA procollagen contains NH2-terminal cystein-rich domain
encoded by exon 2, which is missing from type IIB pro-
collagen. Type IIB procollagen mRNA is found in chondro-
cytes, while type IIA is found in chondroprogenitor cells
during skeletal development. Interestingly, reexpression of
type IIA collagen has recently been observed in human
osteoarthritic cartilage.6
Over the last decade, molecular genetic studies have
confirmed the importance of the collagen network for the
structural integrity of cartilage in the etiopathogenesis of
OA. Linkage of the type II collagen gene (COL2A1) to
familial OA7 was followed by identification of a specific
point mutation in three separate families with early onsetReceived 28 September 1999; accepted 7 January 2000.
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COL2A1 cause a range of more severe diseases of carti-
lage, including spondyloepiphyseal dysplasia, Kniest dys-
plasia, and Stickler and Wagner syndromes.11 Mutations in
genes coding for type IX and type XI collagens have also
been associated with osteoarthritic changes in articular
cartilage.12,13 Based on these recent observations, we
have produced mouse lines carrying mutated type II colla-
gen transgenes in their genome for models of OA and
chondrodysplasias.14–16 Mice heterozygous for a Del1
transgene locus, designated as Del1 (+/−), harboring a
small deletion mutation in type II collagen were found to
develop early OA-like lesions in their knee joints. Here we
present the macroscopic, radiologic and histologic charac-
terization of this phenotype, including a follow-up of the
degenerative changes and alterations in type II collagen
transcripts from birth to old age. As local activation of new
cartilaginous matrix production was observed adjacent to
degenerating cartilage, we also analysed transcription of
type IIA procollagen mRNA.
Materials and methods
EXPERIMENTAL ANIMALS
Del1 (+/−) mice, carrying six copies of an engineered
39 kb Col2a1 transgene with a short deletion mutation,15
were mated with nontransgenic mice sharing the same
C57bl×DBA background. Del1 (+/−) mice (234: 159 males
and 75 females) and their 184 nontransgenic littermates
(133 males and 71 females) serving as controls were used
for the macroscopic and histologic analyses in this study.
The genotypes were determined by PCR amplification of
tail genomic DNA using two oligonucleotide primers flank-
ing the deletion.15 Both Del1 (+/−) and control siblings of
each litter were housed in the same cages, females and
males separated, and allowed to move freely about the
cages. The animals were killed at the age of 3–4, 6–7,
9–10, 15–16 and 20–22 months, weighed and then studied
by means of radiology, stereo microscopy, histology and
immunohistochemistry. In addition, knee joints of 60 male
Del1 (+/−) and 60 control mice, aged between birth and
9 months, were prepared for RNA analyses. The study
protocol was approved by the institutional committee for
animal welfare.
MACROSCOPIC IMAGING OF THE KNEE JOINTS
Selected limbs were imaged in the lateral projection
in a FaxitronY cabinet X-ray system (Hewlett-Packard,
McMinneville, USA) on Min-RY diagnostic film (Kodak,
Windsor, CO, U.S.A.) at 20 kV. Some knee joints were
carefully dissected free from the surrounding tissues and
the articular surfaces were photographed under a stereo
microscope.
TISSUE PREPARATION FOR LIGHT MICROSCOPY
For routine histology, dissected hind limbs were fixed
overnight in fresh 4% paraformaldehyde prepared in phos-
phate buffered saline (PBS). Samples were then decalci-
fied in 10% EDTA in PBS, pH 7.4, and embedded in paraffin
for sectioning in sagittal plane into 5 m thickness through
the entire sample using an LKB 2218 Histo-Range micro-
tome (LKB-Producter Ab, Bromma, Sweden). Sectionswere routinely stained with hematoxylin-eosin. Some serial
sections were also stained with Safranin O,17 using light
green counterstaining, or with Weigert-van Gieson.
POLARIZED LIGHT MICROSCOPY
Polarized light microscopy was performed on 3.5 m
sections after removal of paraffin in xylene for 20 h at 37°C,
rehydration and digestion with bovine testicular hyaluroni-
dase Type IV, 1000 U/ml (Sigma Chemical Co.,
St Louis, MO, U.S.A.) in 0.1 M phosphate buffer (pH 6.9)
for 18 h at 37°C. After rinsing once in 0.1 M phosphate
buffer (pH 6.9) and once in distilled water, the sections
were dehydrated in increasing concentrations of ethanol
and xylene, and mounted in D.P.X. medium (Difco, West
Molesey, Surrey, U.K.). Analysis of the unstained tissue
sections was performed as described previously.18
GRADING OF OA CHANGES
Degenerative changes in the articular cartilage were
evaluated and graded in a total of 177 serially sectioned
knee joints. Sections cut in sagittal plane were stained with
hematoxylin-eosin, examined under light microscope, and
scored into five categories according to Wilhelmi and
Faust19 and Helminen et al.:20 grade 0, no apparent
changes; grade 1, superficial fibrillation of articular (tibial,
femoral or patellar) cartilage; grade 2, defects limited to
uncalcified cartilage; grade 3, defects extending into calci-
fied cartilage; and grade 4, exposure of subchondral bone
at the articular surface. Each knee joint was graded accord-
ing to the highest score observed within the serial sections.
Mean values for each age group were tested for statistical
significance with variance analysis.
EXTRACTION OF TOTAL RNA AND NORTHERN ANALYSES
Skin and muscles were carefully removed around the
knee joints and the samples consisting of the entire knee
joints were dissected at the levels of femoral and tibial
growth plates (N=6 for each group). Total RNA was isolated
from these epiphyseal samples using the guanidinium
isothiocyanate method.21 Prior to RNA extraction the
samples were pulverized under liquid nitrogen. Aliquots of
total RNA were electrophoresed on 1% formaldehyde aga-
rose gels, transferred to Pall Biodyne membranes, and
hybridized as recommended by the supplier (Pall Europe,
Portsmouth, U.K.). For Northern analyses, purified inserts
from mouse cDNA clones pMCol2a1-122 and pMCol2a1-
223 were labeled by random priming to specific activities of
approximately 1×109 cpm/g and used as probes for total
type II procollagen and type IIA procollagen mRNA,
respectively. After high stringency washes the bound
probes were detected and quantified on a Molecular
Imager phosphoimager (Bio-Rad, Hercules, CA, U.S.A.).
RNASE PROTECTION ASSAY
Determination of the ratio of IIA and IIB isoforms of
transgene-derived and endogenous procollagen transcripts
was performed using an RNase protection assay as
described earlier.23,24 Antisense riboprobes were synthe-
sized using TransProbe-T kit (Pharmacia) and 32P-CTP,
and linearized clone pMCol2a1-(2→7), which contains a
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from nucleotide 105 in exon 2 to the end of exon 7.23 Probe
(5×105 cpm) was allowed to hybridize in a solution with
10 g of total RNA at 55°C for overnight. After hybridization
and digestion with RNase A and T1, and proteinase K, the
precipitated samples were electrophoresed on denaturing
4.5% polyacrylamide gels. Fixed and dried gels were
analyzed as above.
IMMUNOHISTOCHEMISTRY
The distribution of type II collagen was studied using a
monoclonal antibody raised against chick type II colla-
gen.25 Representative tissue sections of mouse knee joints
were deparaffinized, rehydrated and digested for 1 h with
bovine testicular hyaluronidase (2000 U/ml) in PBS (pH 5).
After washing, the primary antibody was applied overnight
at +4°C. The sections were washed and incubated con-
secutively with biotin-labeled secondary antibody and alka-
line phosphatase-conjugated streptavidin (Links and Label
kit from BioGenex, San Ramon, CA, U.S.A.), both for
20 min at room temperature, and finally incubated in color
reaction solution containing 0.2 mg/ml naphthol AS-MX,
1 mM levamisole (Sigma) and 0.1 M Tris-HCl (pH 8.2) for
10 min. Immediately before use Fast RedY (Sigma) was
added to a final concentration of 1 mg/ml. The sections
were counterstained with light green.
Results
Transgenic mouse line Del1 was generated in 1990 by
microinjection of complete mouse Col2a1 genes with exon
7 and intron 7 sequences deleted.15 Exon 7 codes for
amino acids 4→18 at the NH2-terminus of the triple helical
domain. Six copies of the transgene were integrated in the
Del1 founder mouse, which resulted in a production of
truncated type II collagen mRNA at a level comparable to
that of the endogenous alleles. The founder and its
transgenic offspring appeared healthy except for a size
reduction by 10–15% persisting through embryonic devel-
opment.16 However, mice homozygous (+/+) for the Del1
locus (12 transgene copies) died at birth with a severe
chondrodysplasia phenotype,15,16,26 demonstrating e.g.
retarded endochondral ossification, disorganization of
growth plate architecture, extended rough ER of chondro-
cytes, and reduced structural strength and collagen fibril
density of cartilages.
The first indication of joint degeneration in Del1 (+/−)
mice came from observations of old animals in their cages;
mice positive for the transgene locus appeared not to moveabout the cages as much as their nontransgenic litter-
mates. Upon visual inspection, the knee joints of Del1
(+/−) mice revealed degenerative changes in the articular
cartilage when compared with controls (Fig. 1). The con-
dyles of Del1 (+/−) mice were flattened and widened, and
their articular surfaces were eroded with the underlying
bone visible in weight-bearing areas of femoral condyles.
The articular surfaces of control mice were smooth and
opalescent.
These findings prompted us to set up a breeding pro-
gram for systematic analysis of the long-term effects of the
type II collagen mutation on articular cartilage during aging.
Both heterozygous Del1 (+/−) and nontransgenic littermate
controls were studied at five age groups of 3–4, 6–7, 9–10,
15–16 and 20–22 months for the development of joint
degeneration. The average weights of Del1 (+/−) animals
were slightly, but significantly, lower than those of controls
between the ages of 3 and 10 months, with a maximal
difference (13–15 %) in 6–10 month old male mice (Table
I). In females the difference was smaller and significant
only at 6–7 months.
RADIOLOGY
The knee radiographs of the controls showed no evi-
dence of degenerative changes (Fig. 2A–D). Calcification
of the menisci and sesamoid bones near the origin of the
hamstring muscles, typical of murine radiology, were seen
from 3 months onwards with little increase in the degree of
calcification. Calcification of the quadriceps tendon was
seen from 6–9 months onwards, but no calcification of the
patellar tendon was seen in the controls (Fig. 2C,D). The
Del1 (+/−) mice showed increasing size and increasing
irregularity of the calcified menisci and sesamoid bonesFig. 1. Stereo microscopic examination of the femoral condyles of
a control (A), and a Del1 (+/−) male mice (B) at the age of 9
months. Flattening of both condyles and erosion of articular
cartilage with exposure of subchondral bone at a weight-bearing
area (arrowheads) are seen in the Del1 (+/−) mouse (B).Table I
Body weights of the experimental animals at different ages
Age
(months)
Male Difference
(%)
Female Difference
(%)Control Del1 (+/−) Control Del1 (+/−)
3–4 33.4±5.1 (66)† 31.2±4.4 (52)* −7 23.3±2.8 (19) 21.7±1.8 (16) −7
6–7 38.5±5.5 (42) 33.6±5.7 (31)*** −13 28.9±5.4 (21) 27.5±7.6 (25)* −5
9–10 38.6±6.7 (26) 33.0±4.8 (23)** −15 30.5±6.1 (21) 27.0±5.2 (18) −11
15–17 37.1±7.7 (20) 35.5±4.7 (16) −4 27.2±1.7 (10) 26.9±4.1 (7) −1
20–22 32.1±2.4 (5) 33.2±4.6 (11) +3 27.1±1.0 (4) 26.6±2.9 (5) −2
†Values indicate mean (g)±SD with the number of analysed animals of each group in parentheses. Statistical
significance of the results was analysed by two-way variance analysis; *P<0.05; **P<0.01; ***P<0.001.
Differences in the mean values between transgenic and wild type groups are expressed in percentages (%).
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chondral bone density from 9 months onward (Fig. 2G). At
15 months the tibial condyles began to exhibit a flattened
outline, from which cartilage erosion could be inferred at
20 months (Fig. 2H,I). Occasionally calcification of the
patellar tendon was also seen at 20 months (Fig. 2J,K).HISTOLOGY
Histological evaluation of the knee joints revealed pro-
gressive erosion and deterioration of the articular cartilage
of tibial, femoral and patellar surfaces. To obtain a quanti-
tative estimate of cartilage erosion, every 20th section of all
serially sectioned knee joints was subjected to thorough
histologic evaluation. The degree of articular cartilage
erosion was graded into five categories with respect to
depth of penetration (Fig. 3). In each age group the Del1
(+/−) offspring exhibited a higher degree of articular carti-
lage erosion. Similar degenerative alterations were also
observed in controls but they appeared significantly later
and not as grave as in the Del1 (+/−) mice. In male mice,
cartilage erosion progressed faster and the defects were
more severe than in the females, within both Del1 (+/−)
and control groups (Table II).
At 3–4 months of age, grade 1 superficial fibrillation of
articular cartilage was observed in all Del1 (+/−) male mice
(Table II, Fig. 3B), while in control mice only a few males
had such defects. Separation of uncalcified cartilage from
calcified cartilage was also observed occasionally as a
preceding step for total loosening of uncalcified cartilage at
the central weight-bearing areas of the tibial and femoral
condyles (Fig. 3C).
At the age of 6–7 months, grade 2 defects with erosion
extending to the border of uncalcified and calcified cartilage
(tidemark) were observed in male Del1 (+/−) mice (Fig.
3E). In controls, grade 1 fibrillations were seen in the knee
joints of about one half of the male mice (Fig. 3D, Table II).
By the age of 9 months, severe degeneration of articular
cartilage was seen in all male Del1 (+/−) mice. Erosion had
progressed either to calcified cartilage (grade 3, Fig. 3G) or
even deeper. In fact, most of the 9-month-old male Del1
(+/−) mice already represented grade 4 alterations with
exposure of subchondral bone. Defects in 9-month-old
control mice (Fig. 3F) corresponded to those seen in
3-month-old Del1 (+/−) mice. The articular cartilage of
femoral condyles was generally less eroded in all age
groups than that of tibial condyles, and the lateral condyles
were frequently more severely affected than the medial
ones.
In addition to cartilage erosion, several other alterations
were observed in the knees of both Del1 (+/−) and control
mice with increasing age. Subchondral bone under defec-
tive cartilage frequently appeared sclerotic (Fig. 3G,I).
Chondrocyte nuclei were pyknotic in defect areas while
clusters of reactive chondrocytes were found at the mar-
gins of the defects on cartilage surfaces and menisci. In
these areas matrix staining with hematoxylin and Safranin
O was higher than in other areas of the same joint,
suggesting attempted cartilage repair (Figs 3G & 4A). In
nonweight-bearing areas and margins of the condyles
such activity probably resulted in new bone formationFig. 2. Radiographs of the knees of male mice in the lateral projection and histological sections of selected regions. A–D are of control mice
at 3 months (A), 6 months (B), 9 months (C) and 15 months (D). E–K are of Del1 (+/−) mice at 3 months (E), 6 months (F), 9 months (G
and I), 15 months (H), and 20 months (J). Histologic sections of Del1 (+/−) mice stained with Weigert-van Gieson illustrate calcification of
the anterior meniscus at 9 months (I, arrowheads pointing at the outlines of calcified matrix). Calcification of the patellar tendon at 20 months
is highlighted by white arrowheads in a radiograph (J) and in a histologic section (K) where the inferior articular surface of patella is marked
with white arrowheads. While the control mice showed no direct evidence of degenerative changes, Del1 (+/−) mice demonstrated
increasing irregularity of the calcified menisci and sesamoid bones (F–I), and increasing subchondral bone density (G, H and J). At 15
months (H) the tibial condyles began to exhibit a flattened outline, from which cartilage erosion could be inferred at 20 months (J, black
arrows). The white bar, in panel I=300 m for histological sections (in panels I and K).Fig. 3. Typical histological views of male knee joints at different
ages. Panels on the left are hematoxylin-eosin stained sagittal
sections of knee joints of control mice at 3 months (A), 6 months
(D), 9 months (F), and 15 months (H). Panels on the right are of
Del1 (+/−) mice at 3 months (B, C), 6 months (E), 9 months (G),
and 15 months (I). Degeneration of articular cartilage was evalu-
ated by grading the defects with respect to the depth of penetra-
tion, scored from 0 to 4. Grade=0 in panel A, grade=1 in panels B,
and F, grade=2 in panels E and H, grade=3 in panel G, grade=4
in panel I. The progression of erosion of the articular cartilage and
degeneration of menisci (G, I) was more pronounced in the Del1
(+/−) mice (panels on the right). Separation of uncalcified cartilage
from calcified cartilage in a 3-month-old Del1 (+/−) mouse (C).
ucc, uncalcified cartilage; cc, calcified cartilage (in C); sb,
subchondral bone (in G); fe, femur; ti, tibia (in E); m, meniscus (in
H). The bar=200 m.
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(Fig. 4B).
Mineralization of menisci was observed from the age of 3
months in some knee joints of both control and Del1 (+/−)
male mice (Fig. 3A,B), and appears to be a normal age-
related phenomenon in mice. Degeneration of the menisci
was apparent in Del1 (+/−) mice from the age of 9 months
onwards (Fig. 3G,I) and in controls from the age of 15
months (Fig. 3H). With increasing age, the menisci became
more fibrillated with disorganized extracellular matrix and
fragmentation (Table III, Figs 2K, 3G,I and 4B). Cyst
formation in trabecular bone and ossicles deep to the
patellar tendon were typically seen in Del1 (+/−) mice from
15 months of age (Table III, Figs 2I and 4C,D). In controlmice such defects appeared only occasionally in 20–22-
month-old mice.
Analysis of other joints for OA-like lesions revealed that
the severe degenerative alterations were mostly confined
to the knee joints. No cartilage degeneration was observed
in the hip joints, and only slight, superficial fibrillation was
observed in the shoulder, elbow, wrist, metacarpal and
phalangeal joints (not shown). Erosion of articular cartilage
could be seen in the tarsal and metatarsal joints of the Del1
(+/−) mice at 15 months while none was observed in the
controls (not shown).
BIREFRINGENCY OF ARTICULAR CARTILAGE
Polarized light microscopy was performed on uncalcified
cartilage in the condylar areas which were located adjacent
to articular cartilage defects but did not show any histologi-
cal signs of cartilage erosion. Birefringency was greatly
reduced in the uncalcified articular cartilage of Del1 (+/−)
mice, indicating decreased and/or disorganized collagen
fibrils in these tissues (Fig. 5).
mRNA LEVELS AND TISSUE DISTRIBUTION OF TYPE II COLLAGEN
To study the production of type II collagen in growing and
aging knee joints, the levels of total (types IIA+IIB) and of
type IIA procollagen mRNA were analysed by Northern
hybridization separately for 6 Del1 and 6 control mice at ten
time points (Fig. 6). The highest levels of total type II
procollagen mRNA were seen during the periods of endo-
chondral ossification and growth (from newborn to the age
of 3 months); thereafter the mRNA levels reduced to a level
representing less than 5% of the peak level. In Del1 (+/−)
mice the mRNA levels for total type II collagen were higher
than in the control animals, due to expression of the
transgene copies in addition to endogenous type II collagen
gene, as also indicated by the RNase protection assay
below. The alternative splice variant type IIA mRNA was
observed during early postnatal development and again in
the aging epiphyses from 3 months onwards. Type IIA
procollagen was expressed both in Del1 and control mice,
but generally at a slightly higher level in Del1 mice. At
6 months, this difference was statistically significant.
Transcription of transgene-derived mRNA was confirmed
by RNase protection assay (Fig. 7). Protected fragments of
transgene derived (320 bp) and endogenous type IIB pro-
collagen mRNA (365 bp) were present in approximate
proportions of 1:1. The assay also demonstrated the pres-
ence of both transgene derived (420 bp) and endogenousFig. 4. Additional osteoarticular defects in Del1 (+/−) male mice. A
tissue section (adjacent to a hematoxylin stained section pre-
sented in Fig. 3G) was stained with Safranin O to demonstrate
intense staining for proteoglycans in the uncalcified cartilage at the
margins of cartilage erosion in the knee joint and in the meniscus
of a 9-month-old Del1 (+/−) mouse (A). Fragmentation of menisci
with disorganized matrix and osteophytes at the age of 15 months
(B). A cyst in trabecular bone (C), and ossicles (*) anterior to
femoral condyle (D) in a Del1 (+/−) mouse at the age of 22
months. Five-micrometre thick paraffin sections were stained with
Safranin O-light green (A) or with hematoxylin-eosin (B, C, D). c,
cyst; fe, femur; m, meniscus; p, patella; t, tendon; ti, tibia. The bar
(in panel A)=100 m in panel A, 200 m in panel B, and 300 m in
panels C and D.Table II
Progression of articular cartilage erosion with age. Defects were categorized into five subgroups with respect to
the depth of penetration into articular cartilage of the knee joints (Fig. 3)
Age
(months)
Male Female
Control Del1 (+/−) Control Del1 (+/−)
3–4 0.33±0.49 (18)†*** 1.94±0.83 (17) 0.00±0.00 (7) 0.50±0.85 (10)
6–7 0.58±0.51 (12)*** 2.43±1.13 (7) 0.50±0.57 (4) 1.57±1.40 (7)
9–10 1.43±0.53 (7)*** 3.62±0.65 (13) 0.63±0.52 (8)* 2.00±1.31 (8)
15–16 1.75±0.97 (12)*** 3.17±0.83 (12) 0.25±0.46 (8)* 1.50±1.38 (6)
20–22 2.67±1.53 (3) 3.71±0.49 (7) 1.00±1.15 (4)* 3.00±1.22 (5)
†Values indicate mean±SD of the erosion grade, scored from 0 to 4, of each age group with number of
analysed animals of each group in parentheses. Statistical significance of the results was analysed by two-way
variance analysis; *P<0.05; **P<0.01; ***P<0.001.
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aging epiphyses both in Del1 (+/−) and control mice.
Immunohistochemistry was used to demonstrate the
tissue distribution of type II collagen throughout the articu-
lar cartilage of 6 and 9 month-old-mice (Fig. 8). No gross
differences were seen between Del1 (+/−) mice and the
controls.
Discussion
Individuals with inherited mutations in genes coding for
type II and other cartilage collagens have an increased
tendency to develop knee joint degeneration.4,11,12 Often
osteoarthritis phenotype is associated with mild chondro-
dysplasia in the same individual. In the present study, Del1
(+/−) mice were slightly smaller than control mice, but no
truly chondrodysplastic features could be identified in theheterozygous animals with six copies of the transgene,
whereas a severe chondrodysplasia phenotype was
observed when the gene dosage was doubled or
higher.15,16,26 Degeneration of the knee joints of Del1 (+/−)
mice begins earlier and progresses much faster than in the
control animals sharing the same genetic background and
similar levels of endogenous type II procollagen mRNA,
indicating that the production of transgene-derived mutant
type II procollagen chains exerts a dominant negative effect
on the structural strength of articular cartilage. Previous
electron microscopic examination indicated enlarged endo-
plasmic reticulum in the growth plate chondrocytes, sug-
gesting accumulation of transgene-derived type II collagen.
Also the extracellular matrix appeared abnormal in struc-
ture with slight reduction and disordered orientation of
collagen fibrils in growth cartilages of newborn Del1(+/−)
mice.15 The reduced birefringency observed in this study atFig. 5. Polarized light microscopic view of the articular cartilage of lateral condyle of proximal tibia of 6 (A) and 9-month-old (C) control mice,
and of 6 (B) and 9-month-old (D) Del1 (+/−) male mice. ac, articular cartilage (the arrow indicating the surface); sb, subchondral bone. The
bar=100 m.Table III
Frequency of additional degenerative defects found in the knee joints of 15–22 month old male mice
Defect Age 15–16 months Age 20–22 months
Control Del1 (+/−) Control Del1 (+/−)
Number of animals 11 12 7 11
Fragmented menisci 2* 10 5 10
(%) 18 83 71 91
Ossicles† 0* 3 2 4
(%) 0 25 29 36
Cysts in trabecular bone 0* 8 2 5
(%) 0 67 29 45
*Values indicate the number of animals with the defect, and the values below their frequency in the group (%).
†Ossicles were found anterior to the femoral condyles, deep to patellar tendon.
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inferiority of the network of collagen fibrils persists in the
uncalcified articular cartilage of adult Del1 (+/−) mice.
Analogous findings have been obtained with transgenic
mice harboring mutant human type II collagen genes,20 in
mice where one of the two endogenous Col2a1 alleles has
been inactivated,27 and in transgenic mice with both 1(IX)
collagen genes inactivated.28
In 1984, Prockop and Kivirikko speculated that mild
mutations in genes coding for fibrillar collagen might render
the tissues involved less resistant to the stresses of several
decades of intermittent weight-bearing.29 The Del1 (+/−)
mice described here provide strong support for their
hypothesis, taking into account the great difference
between the life span of mice and men. In man, the first
clinical evidence becomes detectable at the age of 40–50
years in the weight-bearing areas of articular cartilage, and
progresses from superficial fibrillations and fissures to a
complete disappearance of the articular cartilage with
exposure of subchondral bone and remodeling of the entire
joint.1 In Del1 (+/−) mice, cartilage degeneration begins at
the age of 3 months with fibrillation of the articular surface,
and is followed soon after by the separation of the uncalci-fied and calcified cartilage at the mineralization front (tide-
mark) in the central weight-bearing areas of the condyles.
Apparently the structurally inferior collagen network in Del1
(+/−) mice is incapable of coping with the physiological
forces applied on the articular cartilage. This again results
in a rupture of the collagen network at the mineralization
front and consequent loosening of the uncalcified carti-
lage from the underlying calcified cartilage by the age of
6 months.
It is interesting to note that the initial histological signs of
cartilage degeneration became detectable in the Del1
(+/−) mice as they reached adulthood and the transcription
of the type II collagen gene was greatly reduced. These
observations suggest that growth and active matrix produc-
tion protect against degeneration of articular cartilage. As
the reparative capacity of articular cartilage is remarkably
poor,30 the original strength achieved upon reaching adult-
hood may be an important determinant of the future of
articular cartilage. Interestingly, we found that the produc-
tion of the type IIA procollagen mRNA, characteristic of
chondroprogenitor cells in developing skeletal tissues,5
was reactivated in aging and in degenerating cartilage,
suggesting attempted repair analogous to that seen in
murine fracture callus and in human osteoarthritic
cartilage.6,31
Unlike human OA, the disease in Del1 (+/−) mice
occurred earlier and with greater severity in males than in
females. Similar findings have been made in other mouse
models of OA19,20,32 and inflammatory arthritis.33 The
mechanisms underlying this sex difference between mice
and men in the development of OA remains unknown.
Another difference between human OA and the disease in
mice is the lack of correlation between weight and the
severity of cartilage degeneration.1 As in an earlier study,20
transgenic mice developing OA weighed less than the
controls during the development of the disease. We inter-
pret these results as indicating that the presence of mutant
transgenes enhances development of cartilage degener-
ation despite the slightly more favorable weight-bearing
conditions in Del1 (+/−) mice than in controls.
In Del1 (+/−) mice, the other joint structures also
became defected. Fragmentation of menisci, mineralization
of various joint structures, and formation of cysts of epiphy-
seal trabecular bone were observed in the knee joints by 15
months of age. The knee was clearly the most severely
affected joint in the present and many other murine OA
models19,20 whereas inflammatory arthritis in mice mainly
affects the small joints of the extremities.33 Detailed analy-
sis of Del1 (+/−) mice has revealed degenerative lesions in
other joints, including the temporomandibular joint.34
Despite the differences discussed above, the sequence
of degenerative changes observed in the knee joints of
Del1 (+/−) mice closely parallels those in human OA. This
suggests that the progression of the disease, regardless of
its etiology, follows a final common pathogenetic pathway.
This would indicate that the reactivity of articular cartilage
to a range of different challenges is similar and involves
activation of mechanisms which result in irreparable
articular cartilage damage.
The present genetic model makes it possible to perform
systematic studies on the roles of different pathogenetic
mechanisms involved in the development of OA in the
mouse, e.g. expression of proteases and their inhibitors,
cytokines and growth factors. Furthermore, degenerative
chances in the fibrillar and cellular (ultra)structure of articu-
lar cartilage can also be followed in a systematic way.
Comparison of these data with information available onFig. 6. Compiled results of Northern analyses for type II collagen
mRNA levels in the knee joints of male mice. Total RNA was
isolated from epiphyses of the knee joints dissected at the levels of
femoral and tibial growth plates (with menisci and ligaments
included) of control and Del1 (+/−) mice at different ages shown
below the bars (nb, newborn; d, day; m, month). After hybridization
with cDNA probes detecting total (IIA and IIB forms of) type II
collagen mRNA (A) or the IIA form of the mRNA (B), the hybridi-
zation intensities were quantified by phosphoimaging and normal-
ized per a constant amount of 28S rRNA. The results are shown as
relative units (different scale for panels A and B). Open bars denote
control samples (N=6–9 per time point), and black bars Del1 (+/−)
samples (N=6–9 per time point). Statistical significance of the
difference in mRNA levels between control and Del1 (+/−) mice is
shown above the columns (Student’s t-test; *P<0.05; **P<0.01).
256 A.-M. K. Sa¨a¨ma¨nen et al.: Osteoarthritis-like lesions in transgenic micehuman OA will help to establish the usefulness of the
present mouse model for studies on the pathogenesis of
OA. Such studies are currently under way.
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